NORTHWEST HEALTHCARE PROPERTIES REAL ESTATE INVESTMENT TRUST

Consensus NorthWest Healthcare Properties Real Estate Investment Trust

Equities

NWH.UN

CA6674951059

Market Closed - Toronto S.E. Other stock markets 04:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
5.04 ^CAD	-0.20%		+4.13%	-2.33%

Apr. 17	REITs Brief: Bloomberg Reporting That Ontario Teachers' Pension Plan Weighing $5 Billion Sale of Amica, a private provider of luxury seniors residences	MT
Mar. 18	Northwest Healthcare Properties REIT Appoints Stephanie Karamarkovic As CFO	MT

Evolution of the average Target Price on NorthWest Healthcare Properties Real Estate Investment Trust

Price target over the last 5 years

History of analyst recommendation changes

fa44b58947c803c45fac6eb2.N0hUYfMiXz6xBW1YEeHUU8Zbefx0IhX3bxfBB7bFEdI.AzA4N7BTbGf4PFhsIIWuP5MCNMQ5Vy3CLVX5TMHxYopaChwxv2w8edBwGg~39922be3885bbd0507fabac26ac3eafb

Analyst Recommendations on NorthWest Healthcare Properties Real Estate Investment Trust

National Bank Cuts Price Target on NorthWest Healthcare Properties REIT, Reiterates Stock Rating	23-09-26	MT
BMO on NorthWest Healthcare Properties REIT's Distribution Cut, Trims Target Price to $6	23-09-25	MT
BMO Capital Upgrades Northwest Healthcare to Outperform	22-07-04	MT
Scotiabank Reviews Impact of Higher Rates, Recession Fears on REIT Unit Prices	22-06-21	MT
NorthWest Healthcare Properties REIT Announces Intention to Redeem Two Series of Convertible Debentures Totaling $40 Million with Weighted Average Interest Rate of 7.0%	17-11-09	CI

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

5.04 CAD

Average target price

5.542 CAD

Spread / Average Target

+9.95%

High Price Target

6.5 CAD

Spread / Highest target

+28.97%

Low Price Target

5 CAD

Spread / Lowest Target

-0.79%

Consensus detail

Consensus revision (last 18 months)

Analysts covering NorthWest Healthcare Properties Real Estate Investment Trust

BMO Capital

Ratings for NorthWest Healthcare Properties Real Estate Investment Trust

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Annual profits - Rate of surprise

Company calendar